DEVAL L PATRICK
CIK 1053466 · last filed 2026-06-17
DEVAL L PATRICK is a corporate insider who has filed 68 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for TWLO, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$6.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.27M
6
68
-$6.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TWLO | Director | 18,718 | $197.35 | $3.69M | $0 | 22 | 2026-06-17 |
| TOST | Director | 45,815 | $32.27 | $1.48M | -$1.12M | 14 | 2026-06-16 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 13,743 | $44.96 | $617.9K | -$2.22M | 5 | 2024-06-07 |
| AMWL | Director | 8,895 | $10.75 | $95.6K | $150.0K | 6 | 2023-06-26 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$2.83M | 16 | 2022-10-06 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | — | $18.07 | — | $0 | 1 | 2021-02-03 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | TWLO | Grant (A) | +391 | $0 | EDGAR |
| 2026-06-16 | TOST | Mixed | — | $0 | EDGAR |
| 2026-04-23 | TOST | Sell (S) | −1,667 | -$61.6K | EDGAR |
| 2026-03-17 | TWLO | Grant (A) | +673 | $0 | EDGAR |
| 2025-12-17 | TWLO | Grant (A) | +627 | $0 | EDGAR |
| 2025-09-17 | TWLO | Grant (A) | +763 | $0 | EDGAR |
| 2025-06-17 | TOST | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | TWLO | Grant (A) | +691 | $0 | EDGAR |
| 2025-06-10 | TOST | Exer (M) | — | $0 | EDGAR |
| 2025-03-18 | TWLO | Grant (A) | +618 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.